Cargando…

Carbon ion therapy for ameloblastic carcinoma

Ameloblastic carcinomas are rare odontogenic tumors. Treatment usually consists of surgical resection and sometimes adjuvant radiation. We report the case of a 71 year-old male patient undergoing carbon ion therapy for extensive local relapse of ameloblastic carcinoma. Treatment outcome was favourab...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Alexandra D, Ecker, Swantje, Ellerbrock, Malte, Nikoghosyan, Anna, Debus, Jürgen, Münter, Marc W
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038940/
https://www.ncbi.nlm.nih.gov/pubmed/21294917
http://dx.doi.org/10.1186/1748-717X-6-13
_version_ 1782198148301586432
author Jensen, Alexandra D
Ecker, Swantje
Ellerbrock, Malte
Nikoghosyan, Anna
Debus, Jürgen
Münter, Marc W
author_facet Jensen, Alexandra D
Ecker, Swantje
Ellerbrock, Malte
Nikoghosyan, Anna
Debus, Jürgen
Münter, Marc W
author_sort Jensen, Alexandra D
collection PubMed
description Ameloblastic carcinomas are rare odontogenic tumors. Treatment usually consists of surgical resection and sometimes adjuvant radiation. We report the case of a 71 year-old male patient undergoing carbon ion therapy for extensive local relapse of ameloblastic carcinoma. Treatment outcome was favourable with a complete remission at 6 weeks post completion of radiotherapy while RT-treatment itself was tolerated well with only mild side effects. High dose radiation hence is a potential alternative for patients unfit or unwilling to undergo extensive surgery or in cases when only a subtotal resection is planned or the resection is mutilating.
format Text
id pubmed-3038940
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30389402011-02-15 Carbon ion therapy for ameloblastic carcinoma Jensen, Alexandra D Ecker, Swantje Ellerbrock, Malte Nikoghosyan, Anna Debus, Jürgen Münter, Marc W Radiat Oncol Case Report Ameloblastic carcinomas are rare odontogenic tumors. Treatment usually consists of surgical resection and sometimes adjuvant radiation. We report the case of a 71 year-old male patient undergoing carbon ion therapy for extensive local relapse of ameloblastic carcinoma. Treatment outcome was favourable with a complete remission at 6 weeks post completion of radiotherapy while RT-treatment itself was tolerated well with only mild side effects. High dose radiation hence is a potential alternative for patients unfit or unwilling to undergo extensive surgery or in cases when only a subtotal resection is planned or the resection is mutilating. BioMed Central 2011-02-06 /pmc/articles/PMC3038940/ /pubmed/21294917 http://dx.doi.org/10.1186/1748-717X-6-13 Text en Copyright ©2011 Jensen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Jensen, Alexandra D
Ecker, Swantje
Ellerbrock, Malte
Nikoghosyan, Anna
Debus, Jürgen
Münter, Marc W
Carbon ion therapy for ameloblastic carcinoma
title Carbon ion therapy for ameloblastic carcinoma
title_full Carbon ion therapy for ameloblastic carcinoma
title_fullStr Carbon ion therapy for ameloblastic carcinoma
title_full_unstemmed Carbon ion therapy for ameloblastic carcinoma
title_short Carbon ion therapy for ameloblastic carcinoma
title_sort carbon ion therapy for ameloblastic carcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038940/
https://www.ncbi.nlm.nih.gov/pubmed/21294917
http://dx.doi.org/10.1186/1748-717X-6-13
work_keys_str_mv AT jensenalexandrad carboniontherapyforameloblasticcarcinoma
AT eckerswantje carboniontherapyforameloblasticcarcinoma
AT ellerbrockmalte carboniontherapyforameloblasticcarcinoma
AT nikoghosyananna carboniontherapyforameloblasticcarcinoma
AT debusjurgen carboniontherapyforameloblasticcarcinoma
AT muntermarcw carboniontherapyforameloblasticcarcinoma